Blood Safety

Related Pages

Blood safety encompasses activities intended to mitigate risks of blood transfusion including, in part, donor selection, laboratory testing, component collection, and monitoring transfusion recipients.

Hemovigilance (HV) constitutes one aspect of blood safety, and involves monitoring the entire spectrum of blood donation and transfusion.

The HV Module developed a set of standardized national surveillance procedures used in the monitoring of transfusion-associated adverse reactions, which are aimed at improving patient safety, minimizing morbidity and mortality of transfusion recipients, and identifying emerging complications and infections associated with recipient blood transfusions.

Protocols

2021 HV Module Protocol – March 2021 pdf icon[PDF – 600 KB]
Guidelines and procedures for monitoring transfusion-related reactions and incidents among reporting facilities.

Table of Contents:

 

Supporting Chapters

Top of Page

Data Collection Forms & Instructions

All Data Collection Forms are Print-only

HV Module Annual Facility Surveys

Please select the appropriate annual facility survey.

HV Module Monthly Reporting Plan

HV Module Monthly Reporting Denominators

HV Module Adverse Reaction Forms

Please select the appropriate adverse reaction form.

HV Module Incident Form

HV Module Monthly Incident Summary

Top of Page
BV Training
Educational Roadmap
FAQs About Hemovigilance Module
Quick Reference Guides
Analysis Resources
Electronic Reporting

Quick Reference Guides

Top of Page

E-learning NHSN

Training

Newsletters

Newsletters / Members Meeting Updates

e-mail icon

E-mail Updates

United States map

State-based HAI Prevention Activities

Page last reviewed: March 23, 2021
Content source: Centers for Disease Control and Prevention , National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) , Division of Healthcare Quality Promotion (DHQP)